Collectively, the data demonstrate that the NSG-Pro mouse model provides physiological levels of hPRL and improves the growth of common human ER+ breast cancer cell lines as xenografts while retaining the ability of NSG mice to host ER-negative tumors. Here, PRLR is linked to breast cancer.